Search Result "non receptor tyrosine kinase inhibitors"


Review Article

Next-generation Bruton’s Tyrosine Kinase (BTK) Inhibitors PotentiallyTargeting BTK C481S Mutation- Recent Developments and Perspectives

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 20 Year: 2022 Page: 1674-1691
Author(s):

Review Article

Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 4738-4755
Author(s): Giambattista Marotta,Filippo Basagni,Michela Rosini,Anna Minarini

Review Article

Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) andtheir Role in the Treatment of Cancer: A Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 20 Year: 2022 Page: 3370-3381
Author(s): Ananda Kumar Chettupalli,Mohammad Amjad Kamal

Review Article

Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Modelsand Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 28 Issue: 6 Year: 2022 Page: 437-444
Author(s): Anja Steinmaurer,Isabella Wimmer,Thomas Berger,Paulus S Rommer,Johann Sellner

Research Article

Identification of Multi-kinase Allosteric Inhibitors of Oncogenic TargetsEGFR1, PI3K, and BRAF Kinase

Journal: Current Computer-Aided Drug Design
Volume: 18 Issue: 7 Year: 2022 Page: 506-518
Author(s): Kavita Kumari Kakarala

Current Frontiers

In vivo PET Imaging of EGFR Expression: An Overview of Radiolabeled EGFR TKIs

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 28 Year: 2022 Page: 2329-2342
Author(s):

Review Article

A Perspective on EGFR and Proteasome-based Targeted Therapy for Cancer

Journal: Current Drug Targets
Volume: 23 Issue: 15 Year: 2022 Page: 1406-1417
Author(s):

Review Article

Virtual Screening and Molecular Docking: Discovering Novel c-KITInhibitors

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 166-188
Author(s): Hamilton Mitsugu Ishiki,Luciana Scotti,Marcus T. Scotti,João Luiz Sobral de Medeiros,Edson Mareco Assunção,Angela Cristina Gomes,Fernanda Mello Tavares

Mini-Review Article

Mesenchymal Epithelial Transition (MET): A Key Player in ChemotherapyResistance and an Emerging Target for Potentiating Cancer Immunotherapy

Journal: Current Cancer Drug Targets
Volume: 22 Issue: 4 Year: 2022 Page: 269-285
Author(s): Kenneth K.W. To,William C.S. Cho

Current Frontiers

Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 1 Year: 2022 Page: 891-920
Author(s): Mohammad Ali Ebrahimzadeh

Previous   Next

Go To   Results 1 - 1 of 215

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy